B3Q-32281-75492
2 vaccinations
11 coded responses
14 check-ins
11 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 430 / OH
- Registered
- 2021-08-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Moderna
-
2021-08-19
Dose 2 — Moderna
-
2021-08-20
Registered in v-safe
-
2021-08-20
Survey response — days 1–6 daily, dose 2MedDRA: Guillain-Barre syndrome — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Guillian BarreMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Report sent to call center — days 1–6 daily, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-21
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia, Guillain-Barre syndrome — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Weakness. GBSMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-23
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia, Guillain-Barre syndrome — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Weakness. Gillian barreMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-24
Survey response — days 1–6 daily, dose 2MedDRA: Muscular weakness — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Muscle weaknessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia, Guillain-Barre syndrome, Walking aid user — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Weakness. GBS. walking with a cane. Starting physical therapy.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-27
-
2021-08-28
Survey response — day 7, dose 2MedDRA: Asthenia, Guillain-Barre syndrome — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Weakness. Guillian barre syndromeMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-02
-
2021-09-10
Survey response — day 21, dose 2MedDRA: Condition aggravated, Myalgia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Days where I have worsening myalgia and weakness.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-16
-
2021-09-23
Survey response — day 35, dose 2MedDRA: Asthenia, Fatigue, Office visit, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Worsening weakness, fatigue, pain · Healthcare visit (other): PCPMedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Report sent to call center — day 35, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-10-02
Survey response — day 42, dose 2MedDRA: Asthenia, Pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening weakness and generalized body pain.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Report sent to call center — day 42, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-07
-
2021-10-07
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-11-19
Survey response — 3 months, dose 2MedDRA: Acupuncture, Asthenia, Fatigue, Massage, Myalgia, Physiotherapy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Intermittent worsening of muscle pain, weakness, fatigue. · Healthcare visit (other): Physical therapy, massage therapy, acupuncture.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-19
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2021-11-24
- 2022-02-19
-
2022-08-19
Survey response — 12 months, dose 2MedDRA: Asthenia, Brain fog — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Continued weakness, brain fogMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Moderna | No |
| 2 | 2021-08-19 | Moderna | No |
Call center
4 call center cases
3 successful · 1 unsuccessful
VAERS report filed, before or during a call: 4
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Guillian Barre
Systemic reaction (other): Weakness. GBS
Systemic reaction (other): Weakness. Gillian barre
Systemic reaction (other): Muscle weakness
Systemic reaction (other): Weakness. GBS. walking with a cane. Starting physical therapy.
Release 9 — day 7, dose 2
Systemic reaction (other): Weakness. Guillian barre syndrome
Release 9 — day 21, dose 2
Symptoms: Days where I have worsening myalgia and weakness.
Release 9 — day 35, dose 2
Release 9 — day 42, dose 2
Symptoms: Worsening weakness and generalized body pain.
Release 10 — 3 months, dose 2
Symptoms: Intermittent worsening of muscle pain, weakness, fatigue.
Healthcare visit (other): Physical therapy, massage therapy, acupuncture.
Release 12 — 12 months, dose 2
Symptoms: Continued weakness, brain fog
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Acupuncture | · | · | ✓ |
| HCVO | Massage | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Physiotherapy | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Asthenia | ✓ | · | ✓ |
| SRO | Guillain-Barre syndrome | ✓ | · | ✓ |
| SRO | Muscular weakness | ✓ | · | ✓ |
| SRO | Walking aid user | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release